Charlesson's News

11/11/2008:

Charlesson selected to receive two-year funding from Oklahoma EDGE

11/04/2008:

Charlesson Senior Vice-President, Dr. Mostafa Analoui, to speak at the 21st Century Medicine: Breakthroughs and Challenges Conference

10/21/2008:

Charlesson Senior Vice-President, Dr. Mostafa Analoui, to speak at the 13th Annual Drug Delivery Partnerships Meeting">

08/01/2008:

Charlesson Senior Vice-President, Dr. Mostafa Analoui, to speak at the 13th Annual World Congress of Drug Discovery & Development of Innovative Therapeutics.

07/22/2008:

Charlesson scientist, Dr. Rafal Farjo, receives $241,000 Phase I SBIR grant from the National Institutes of Health to develop CLT-005 for Retinal Inflammation and Neovascularization

06/05/2008:

Mike Moradi, CEO of Charlesson, featured in The Oklahoman

05/22/2008:

Charlesson scientist, Dr. Ying Chen, receives $90,000 award from the Oklahoma Center for Advancement in Science and Technology to develop CLT-009 as a treatment for Age-Related Macular Degeneration

04/23/2008:

Charlesson scientist, Dr. Drew Wassel, receives $204,280 award from the Oklahoma Center for Advancement in Science and Technology to develop nanoparticle drug formulations

04/21/2008:

Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology

03/11/2008:

Charlesson scientist, Dr. Rafal Farjo, receives $1,388,000 Phase II SBIR grant from the National Insitutues of Health to develop CLT-004 for Diabetic Retinopathy and Age-Related Macular Degeneration.